Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
Bejjani A, Khairani CD, Assi A, Piazza G, Sadeghipour P, Talasaz AH, Fanikos J, Connors JM, Siegal DM, Barnes GD, Martin KA, Angiolillo DJ, Kleindorfer D, Monreal M, Jimenez D, Middeldorp S, Elkind MSV, Ruff CT, Goldhaber SZ, Krumholz HM, Mehran R, Cushman M, Eikelboom JW, Lip GYH, Weitz JI, Lopes RD, Bikdeli B. Bejjani A, et al. Among authors: middeldorp s. J Am Coll Cardiol. 2024 Jan 23;83(3):444-465. doi: 10.1016/j.jacc.2023.10.038. J Am Coll Cardiol. 2024. PMID: 38233019 Review.
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. Among authors: middeldorp s. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A; CALISTO Study Group. Decousus H, et al. Among authors: middeldorp s. N Engl J Med. 2010 Sep 23;363(13):1222-32. doi: 10.1056/NEJMoa0912072. N Engl J Med. 2010. PMID: 20860504 Free article. Clinical Trial.
The Incidence of Pulmonary Embolism in Hospitalized Non-ICU Patients with COVID-19 during the First Wave: A Multicenter Retrospective Cohort Study in the Netherlands.
Maas AFG, Wyers C, Dielis A, Barten DG, van Kampen VEM, van der Krieken TE, de Kruif M, Simsek S, Spaetgens B, van Haaps T, Appelman B, Gritters NC, Doornbos S, Moeniralam HS, Noordzij PG, Reidinga A, Douma RA, Nossent EJ, Beudel M, Elbers P, Middeldorp S, van Es N, van den Bergh JPW, van Osch FHM. Maas AFG, et al. Among authors: middeldorp s. J Vasc Res. 2024 Apr 17:1-8. doi: 10.1159/000538312. Online ahead of print. J Vasc Res. 2024. PMID: 38631294
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B. Talasaz AH, et al. Among authors: middeldorp s. Nat Rev Cardiol. 2024 Mar 20. doi: 10.1038/s41569-024-01003-3. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 38509244 Review.
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.
Schulman S, Arnold DM, Bradbury CA, Broxmeyer L, Connors JM, Falanga A, Iba T, Kaatz S, Levy JH, Middeldorp S, Minichiello T, Nazy I, Ramacciotti E, Resnick HE, Samama CM, Sholzberg M, Thachil J, Zarychanski R, Spyropoulos AC; International Society on Thrombosis and Haemostasis. Schulman S, et al. Among authors: middeldorp s. J Thromb Haemost. 2024 Mar 18:S1538-7836(24)00113-2. doi: 10.1016/j.jtha.2024.02.011. Online ahead of print. J Thromb Haemost. 2024. PMID: 38503600 Free article.
VTE Risk Assessment and Prevention in Pregnancy.
O'Rourke E, Faryal R, Blondon M, Middeldorp S, Ní Áinle F. O'Rourke E, et al. Among authors: middeldorp s. Hamostaseologie. 2024 Feb 26. doi: 10.1055/a-2238-4681. Online ahead of print. Hamostaseologie. 2024. PMID: 38408592 Free article.
Concerns about the ALIFE2 trial - Authors' reply.
Quenby S, Ewington L, Hamulyák E, Scheres LJ, Goddijn M, Middeldorp S. Quenby S, et al. Among authors: middeldorp s. Lancet. 2024 Jan 20;403(10423):248. doi: 10.1016/S0140-6736(23)02336-X. Lancet. 2024. PMID: 38245246 No abstract available.
Venous thromboembolism among physically active young adult females.
Shapiro M, Hamulyák EN, Leader A, Landau R, Middeldorp S, Gurevich-Shapiro A. Shapiro M, et al. Among authors: middeldorp s. Res Pract Thromb Haemost. 2023 Oct 20;7(8):102236. doi: 10.1016/j.rpth.2023.102236. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193067 Free PMC article.
458 results